271 related articles for article (PubMed ID: 34372524)
1. Screening for Hepatocellular Carcinoma in Patients with Hepatitis B.
Sachar Y; Brahmania M; Dhanasekaran R; Congly SE
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372524
[TBL] [Abstract][Full Text] [Related]
2. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening.
Robotin MC; Kansil M; Howard K; George J; Tipper S; Dore GJ; Levy M; Penman AG
J Hepatol; 2009 May; 50(5):990-8. PubMed ID: 19303657
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
[TBL] [Abstract][Full Text] [Related]
4. Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy.
Wong GL; Wong VW
World J Gastroenterol; 2013 Oct; 19(39):6515-22. PubMed ID: 24151375
[TBL] [Abstract][Full Text] [Related]
5. Effects of antiviral treatment on the risk of hepatocellular cancer in patients with chronic viral hepatitis.
Stournaras E; Neokosmidis G; Stogiannou D; Protopapas A; Tziomalos K
Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1277-1282. PubMed ID: 30179906
[TBL] [Abstract][Full Text] [Related]
6. Earlier Alanine Aminotransferase Normalization During Antiviral Treatment Is Independently Associated With Lower Risk of Hepatocellular Carcinoma in Chronic Hepatitis B.
Choi J; Kim GA; Han S; Lim YS
Am J Gastroenterol; 2020 Mar; 115(3):406-414. PubMed ID: 31895708
[TBL] [Abstract][Full Text] [Related]
7. Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting.
Wong CR; Garcia RT; Trinh HN; Lam KD; Ha NB; Nguyen HA; Nguyen KK; Levitt BS; Nguyen MH
Dig Dis Sci; 2009 Dec; 54(12):2712-21. PubMed ID: 19876735
[TBL] [Abstract][Full Text] [Related]
8. Screening is associated with a lower risk of hepatocellular carcinoma-related mortality in patients with chronic hepatitis B.
Su F; Weiss NS; Beste LA; Moon AM; Jin GY; Green P; Berry K; Ioannou GN
J Hepatol; 2021 Apr; 74(4):850-859. PubMed ID: 33245934
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis B.
Jun CH; Hong HJ; Chung MW; Park SY; Cho SB; Park CH; Joo YE; Kim HS; Choi SK; Rew JS
World J Gastroenterol; 2013 Oct; 19(40):6834-41. PubMed ID: 24187458
[TBL] [Abstract][Full Text] [Related]
10. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
Ringelhan M; O'Connor T; Protzer U; Heikenwalder M
J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558
[TBL] [Abstract][Full Text] [Related]
11. Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B: A Korean Nationwide Cohort Study.
Choi J; Kim HJ; Lee J; Cho S; Ko MJ; Lim YS
JAMA Oncol; 2019 Jan; 5(1):30-36. PubMed ID: 30267080
[TBL] [Abstract][Full Text] [Related]
12. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
[TBL] [Abstract][Full Text] [Related]
13. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
Liaw YF
Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980
[TBL] [Abstract][Full Text] [Related]
14. Managing hepatitis B to prevent liver cancer: recent advances.
Strasser SI
Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):409-15. PubMed ID: 24580046
[TBL] [Abstract][Full Text] [Related]
15. Effective viral suppression is necessary to reduce hepatocellular carcinoma development in cirrhotic patients with chronic hepatitis B: Results of a 10-year follow up.
Zhang W; Wang X; Wang Y; Zhao X; Duan W; Wang Q; Wu X; Kong Y; Ma H; You H; Ou X; Jia J
Medicine (Baltimore); 2017 Nov; 96(44):e8454. PubMed ID: 29095292
[TBL] [Abstract][Full Text] [Related]
16. Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis.
Huang ZH; Lu GY; Qiu LX; Zhong GH; Huang Y; Yao XM; Liu XH; Huang SJ; Wu T; Yuan Q; Wang YB; Su YY; Zhang J; Xia NS
BMC Cancer; 2022 Mar; 22(1):287. PubMed ID: 35300634
[TBL] [Abstract][Full Text] [Related]
17. Prevention of hepatocellular carcinoma: beyond hepatitis B vaccination.
Kim MN; Han KH; Ahn SH
Semin Oncol; 2015 Apr; 42(2):316-28. PubMed ID: 25843736
[TBL] [Abstract][Full Text] [Related]
18. A long-term study of the effects of antiviral therapy on survival of patients with HBV-associated hepatocellular carcinoma (HCC) following local tumor ablation.
Hann HW; Coben R; Brown D; Needleman L; Rosato E; Min A; Hann RS; Park KB; Dunn S; DiMarino AJ
Cancer Med; 2014 Apr; 3(2):390-6. PubMed ID: 24519810
[TBL] [Abstract][Full Text] [Related]
19. Cost evaluation of PAGE-B risk score guided HCC surveillance in patients with treated chronic hepatitis B.
Sprinzl MF; Feist C; Koch S; Kremer WM; Lackner KJ; Weinmann A; Galle PR
BMC Health Serv Res; 2021 Aug; 21(1):846. PubMed ID: 34419018
[TBL] [Abstract][Full Text] [Related]
20. Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high risk.
Ren P; Cao Z; Mo R; Liu Y; Chen L; Li Z; Zhou T; Lu J; Liu Y; Guo Q; Chen R; Zhou H; Xiang X; Cai W; Wang H; Bao S; Xu Y; Gui H; Xie Q
Expert Opin Biol Ther; 2018 Oct; 18(10):1085-1094. PubMed ID: 30182763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]